PHASE I/II TRIAL OF PERIOPERATIVE OXALIPLATIN (O), CAPECITABINE (C) AND IRINOTECAN (I) FOR PATIENTS (PTS) WITH LOCALLY ADVANCED GASTRIC CANCER

被引：0

作者：

Utelbayeva, A. ^{[1
]}

Arzykulov, Z. ^{[1
]}

Izhanov, E. ^{[1
]}

机构：

[1] Kazakh Sci Res Inst Oncol & Radiol, Alma Ata, Kazakhstan

来源：

ANNALS OF ONCOLOGY | 2010年 / 21卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：45 / 46

页数：2

共 50 条

[1] A Phase I Study of Neoadjuvant Capecitabine, Oxaliplatin, and Irinotecan (XELOXIRI) in Patients with Locally Advanced Rectal Cancer
Kudo, Toshihiro
Takemasa, Ichiro
Hata, Tsuyoshi
Sakai, Daisuke
Takahashi, Hidekazu
Haraguchi, Naotsugu
Nishimura, Junichi
Hata, Taishi
Matsuda, Chu
Satoh, Taroh
Mizushima, Tsunekazu
Mori, Masaki
Doki, Yuichiro
ONCOLOGY, 2019, 97 (04) : 211 - 216
[2] A phase I/II study of capecitabine (X), irinotecan (I) and oxaliplatin (O) as first-line therapy in patients (PTS) with advanced or metastatic colorectal cancer (MCRC)
Maroun, Jean A.
Jonker, Derek
Goel, Rakesh
Cripps, Christine
Lister, Diane
Chiritescu, Gabriela
ANNALS OF ONCOLOGY, 2006, 17 : 119 - 119
[3] Phase I Study of Neoadjuvant Chemotherapy with Capecitabine and Oxaliplatin for Locally Advanced Gastric Cancer
Satake, Hironaga
Kondo, Masato
Mizumoto, Motoko
Kotake, Takeshi
Okita, Yoshihiro
Ogata, Takatsugu
Hatachi, Yukimasa
Yasui, Hisateru
Miki, Akira
Imai, Yukihiro
Ichikawa, Chihiro
Murotani, Kenta
Kotaka, Masahito
Kato, Takeshi
Kaihara, Satoshi
Tsuji, Akihito
ANTICANCER RESEARCH, 2017, 37 (07) : 3703 - 3710
[4] A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer
Kim, Kyoung Ha
Park, Young Suk
Chang, Myung Hee
Kim, Hyo Song
Jun, Hyun Jung
Uhm, Jieun
Yi, Seong Yoon
Lim, Do Hyoung
Ji, Sang Hoon
Park, Min Jae
Lee, Jeeyun
Park, Se Hoon
Park, Joon Oh
Lim, Ho Yeong
Kang, Won Ki
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (02) : 347 - 353
[5] A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer
Kyoung Ha Kim
Young Suk Park
Myung Hee Chang
Hyo Song Kim
Hyun Jung Jun
Jieun Uhm
Seong Yoon Yi
Do Hyoung Lim
Sang Hoon Ji
Min Jae Park
Jeeyun Lee
Se Hoon Park
Joon Oh Park
Ho Yeong Lim
Won Ki Kang
Cancer Chemotherapy and Pharmacology, 2009, 64 : 347 - 353
[6] A Phase I Study of Irinotecan, Capecitabine (Xeloda), and Oxaliplatin in Patients With Advanced Colorectal Cancer
Maroun, Jean
Marginean, Horia
Jonker, Derek
Cripps, Christine
Goel, Rakesh
Asmis, Timothy
Goodwin, Rachel
Chiritescu, Gabriela
CLINICAL COLORECTAL CANCER, 2018, 17 (02) : E257 - E268
[7] PHASE I AND PHARMACOLOGIC STUDY OF DOCETAXEL (D), OXALIPLATIN(O), CAPECITABINE (C) FOR UNTREATED PATIENTS (PTS) AFFECTED BY ADVANCED GASTRIC CANCER (AGC)
Buonadonna, A.
Miolo, G.
Corona, G.
Elia, C.
Toffoli, G.
Turchet, E.
Tumolo, S.
Lo Re, G.
Frustaci, S.
ANNALS OF ONCOLOGY, 2010, 21 : 261 - 261
[8] A phase II trial of capecitabine (X) and irinotecan (I), in a biweekly schedule, for patients (Pts) with advanced/metastatic colorectal cancer (MCRC).
Garcia-Alfonso, P
Gonzalez-Arenas, C
Gonzalez-Flores, E
Molina, M
Muñoz, A
Abad, G
Garcia-Adrian, S
Lopez, P
Belon, J
Perez-Manga, G
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 290S - 290S
[9] A phase I/II trial of docetaxel (D) and oxaliplatin (O) in patients with advanced gastric cancer (AGC)
Park, Y.
Kim, K.
Choi, M.
Hong, J.
Lee, E.
Park, M.
Kim, H.
Lee, Y.
Park, J.
Lim, H.
Kang, W.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[10] Phase II multicenter sequential study of oxaliplatin (O) and capecitabine (C) followed by irinotecan (I) and capecitabine (C) in first line advanced colorectal cancer (CRC).
Cassinello, J
Alvarez, JV
García-López, MJ
Pujol, E
Colmenarejo, A
de Segovia, F
Marcos, F
Filipovich, E
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 257S - 257S

← 1 2 3 4 5 →